Dr. Harry Staszewski, MD
- Medicare services, 2024
- 169,445
- Medicare patients, 2024
- 1,471
- Part D claims, 2024
- 1,207
- Publications
- 7
- Clinical trials
- 3
- Practice address
- 1 Research Rd, Ridge, NY 11961
- Practice phone
- Call (631) 751-3000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Port Jefferson Station Medical Oncology
Multi-specialty group site · Ridge, New York
Find Dr. Staszewski's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Harry Staszewski is a hematologist and oncologist in Ridge, New York
Dr. Staszewski practices at Port Jefferson Station Medical Oncology in Ridge, New York.
Dr. Staszewski's NPI, 1366495509, was assigned on May 18, 2006. Dr. Staszewski graduated from Yale University School of Medicine in 1978. Dr. Staszewski holds New York license 140378.
- NPI
- 1366495509NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6204910458
- NPI enumeration date
- May 18, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (631) 751-3000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 74
- Medical school graduation
- 1978
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Harry Staszewski practices at Port Jefferson Station Medical Oncology in Ridge, New York
Dr. Staszewski's primary practice is Port Jefferson Station Medical Oncology, at 1 Research Rd, Ridge, NY 11961. The practice phone is (631) 751-3000.
- Port Jefferson Station Medical Oncology1 Research Rd, Ridge, NY 11961Phone(631) 751-3000
Source: Dmand AI Affiliation Data
Dr. Harry Staszewski is affiliated with 3 sites of care and 2 medical groups
Dr. Staszewski's primary practice is Port Jefferson Station Medical Oncology in Ridge, New York. Dr. Staszewski is also affiliated with Mather Hospital. The medical group on file is New York Cancer & Blood Specialists. Dmand AI also links Dr. Staszewski to 1 more group practice or clinic and 1 medical group, each named with a free account.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Harry Staszewski's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Staszewski practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Port Jefferson Station Medical Oncology | Available with a free account |
| +2 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Harry Staszewski is one of 996 hematologists and oncologists in New York
Hematology and oncology is Dr. Staszewski's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Staszewski is licensed in New York.
Specialties and state licenses
- Hematology and oncology, New YorkPrimary
Hematologists and oncologists near Dr. Staszewski
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Harry Staszewski billed Medicare for 169,445 services in 2024
CMS data shows 169,445 Medicare services from Dr. Staszewski across 94 procedure codes in 2024, for 1,471 Medicare patients. Medicare paid $1,937,380 for them. Every service was in an office.
Dr. Staszewski's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 97,2632024: 141,35245%
- Lab and pathology
- 2023: 13,8842024: 19,46640%
- Surgery
- 2023: 2,2592024: 2,99433%
- Tests and treatments
- 2023: 2,0592024: 2,92842%
- Office and hospital visits
- 2023: 2,6232024: 2,6652%
- Other services
- 2023: 372024: 408%
Dr. Staszewski compared with the New York median for hematologists and oncologists, 2024
- Dr. Staszewski
- New York median
- Medicare services
- 169,445vs 668253.7 times
- Medicare patients
- 1,471vs 2107.0 times
- Part D claims
- 921vs 2583.6 times
Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.
Dr. Staszewski's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Staszewski?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Staszewski and other hematologists and oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Harry Staszewski treated 1,471 Medicare patients in 2024, average age 76
CMS counts 1,471 Medicare patients who saw Dr. Staszewski in 2024. The largest group is 75 to 84, with 603 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Staszewski's median patient age at 60, with 65% women.
Dr. Staszewski's Medicare patients by age, 2024
Dr. Staszewski's Medicare patients by sex, 2024
- Women84557%
- Men62643%
Chronic conditions among Dr. Staszewski's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis53%
- Ischemic heart disease45%
- Cancer40%
- Chronic kidney disease40%
- Diabetes40%
- Anxiety31%
Share of Medicare patients with each condition. A patient can have several.
Dr. Staszewski's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 60
Patient panel by sex, all payers
- Women65%
- Men32%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Harry Staszewski wrote 1,207 Medicare Part D claims in 2024
In 2024, Dr. Staszewski wrote 1,207 Medicare Part D claims for 163 patients. 48% of them were for generic drugs. CMS names the drug for 921 of them, across 35 drugs with 11 or more claims each, at $4,457,196 in total drug cost. In 2023, CMS named 824 claims across 31 drugs.
Dr. Staszewski's Part D claims by kind of drug, 2024
- Generic577 claims48%
- Brand-name630 claims52%
Dr. Staszewski's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Staszewski's Part D claims, 2024
- Antibiotics2%21 of 1,207 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 8242024: 92112%
Drugs named by CMS: 35 in 2024, 31 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Harry Staszewski scored 100 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Staszewski for performance year 2024, reported as part of a group. Dr. Staszewski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Staszewski as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Staszewski's MIPS scores, performance year 2024
- 100of 100Final score
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Harry Staszewski has 7 publications on record
Dmand AI links 7 papers to Dr. Staszewski, published from 2010 to 2023. 2012 was the busiest year, with 2. Dr. Staszewski has published most often in Am J Med. Dr. Staszewski's most frequent co-authors are Martin Christopher Barnes, MD, John J. Crowley and Burke A. Cunha, MD.
Dr. Staszewski's papers by year, 2010 to 2023
Dr. Staszewski's most frequent co-authors
- Martin Christopher Barnes, MD1 shared paper
- John J. Crowley1 shared paper
- Burke A. Cunha, MD1 shared paper
Recent publications by Dr. Staszewski
Am J Med
J Neurooncol
See who Dr. Staszewski researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Staszewski works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Harry Staszewski has worked on 3 clinical trials
Dmand AI links Dr. Staszewski to 3 clinical trials. Conditions studied include Leukemia, Megakaryoblastic, Acute, Pancreatic Neoplasms and Small Cell Lung Carcinoma.
Clinical trials with Dr. Staszewski by phase
- NonePhase 1: no trials
- NonePhase 2: no trials
- 1Phase 2/3: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Staszewski's trials
- Leukemia, Megakaryoblastic, Acute
- Pancreatic Neoplasms
- Small Cell Lung Carcinoma
- Leukemia, Erythroblastic, Acute
- Neoplasm Metastasis
Investigators on the most trials with Dr. Staszewski
- Jessica Kaplan Altman, MD1 shared trial
- Faiz Anwer, MD1 shared trial
- Ehab L. Atallah, MD1 shared trial
Recent clinical trials with Dr. Staszewski
A Randomized Phase 2/3 Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer Whose Disease Has Progressed or Recurred (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Harry Staszewski received $982 in industry payments from 2017 to 2025
CMS Open Payments shows 40 general payments to Dr. Staszewski from 17 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 81% of the total. Novartis Pharmaceuticals Corporation paid the most, $186. It also lists 7 research payments totaling $4,718 from 2021 to 2022.
General payments to Dr. Staszewski by program year, 2017 to 2025
General payments to Dr. Staszewski by kind, 2017 to 2025
- Food and beverage$79981%
- Education$18219%
Companies that paid Dr. Staszewski the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Harry Staszewski graduated from Yale University School of Medicine
Dr. Staszewski graduated from Yale University School of Medicine in 1978.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Harry Staszewski's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Harry Staszewski
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Harry Staszewski's NPI number?
Dr. Harry Staszewski's NPI number is 1366495509. It was assigned on May 18, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Harry Staszewski?
Dr. Harry Staszewski is a hematologist and oncologist in Ridge, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Harry Staszewski practice?
Dr. Staszewski practices at 1 Research Rd, Ridge, NY 11961. Dr. Staszewski's primary practice is Port Jefferson Station Medical Oncology in Ridge, New York. Dmand AI also links Dr. Staszewski to 1 group practice or clinic and 1 medical group.
What is Dr. Harry Staszewski's office phone number?
The practice phone on file for Dr. Staszewski is (631) 751-3000.
What is Dr. Harry Staszewski's medical license number?
Dr. Staszewski holds New York license 140378.
Which hospitals is Dr. Harry Staszewski affiliated with?
Dr. Staszewski is affiliated with Mather Hospital.
What medical group is Dr. Harry Staszewski part of?
Dr. Staszewski is linked to New York Cancer & Blood Specialists. Dmand AI links Dr. Staszewski to 1 more medical group.
Does Dr. Harry Staszewski accept Medicare?
Yes. CMS data shows Dr. Staszewski billed Medicare for 169,445 services in 2024, and Dr. Staszewski accepts Medicare assignment.
Does Dr. Harry Staszewski offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Staszewski as offering telehealth services.
What is Dr. Harry Staszewski's MIPS score?
Dr. Staszewski's MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. Harry Staszewski see?
CMS counts 1,471 Medicare patients who saw Dr. Staszewski in 2024, with an average age of 76.
What services does Dr. Harry Staszewski bill to Medicare?
In 2024, Dr. Staszewski's most billed Medicare services were injected or infused drug (J1439), injected or infused drug (J0896) and injected or infused drug (J0881).
Where did Dr. Harry Staszewski go to medical school?
Dr. Staszewski graduated from Yale University School of Medicine in 1978.
What drugs does Dr. Harry Staszewski prescribe most?
In 2024 Medicare Part D data, Dr. Staszewski's most prescribed drugs by claims were Anastrozole, Aranesp and Hydroxyurea.
Has Dr. Harry Staszewski received payments from drug or device companies?
CMS Open Payments shows $982 in general payments to Dr. Staszewski from 17 companies from 2017 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Harry Staszewski been practicing?
Dr. Staszewski graduated from medical school in 1978, 48 years ago.
Does Dr. Harry Staszewski do research?
Dmand AI links 7 publications to Dr. Staszewski, published from 2010 to 2023. Dr. Staszewski has worked on 3 clinical trials.
Who does Dr. Harry Staszewski publish with?
Dr. Staszewski's most frequent co-authors are Martin Christopher Barnes, MD (1 shared paper), John J. Crowley (1 shared paper) and Burke A. Cunha, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card